Filter Results :

Your search for Biopharmaceutical returned 94 reports

Sort by


Single-Use Technologies for Biopharmaceuticals: Global Markets

20 May 2015  |  Published by:  BCC Research
The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019. This report provides:-An overview of biopharm...

$ 6,650.00

Read More

Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019

01 May 2015  |  Published by:  MarketsandMarkets
Report Description Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have l...

$ 4,650.00

Read More

Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummarySino Biopharmaceutical Limited (Sino) is a pharmaceutical company. The company operates through Chinese Medicines and Chemical Medicines segment, Investment Segment, and Other Segments. Its Chinese medicines and chemical medicines segment manufactures, sells and distributes modernized Chinese...

$ 300.00

Read More

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical products in the areas of unmet clinical needs. The company has three product can...

$ 300.00

Read More

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryRegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. Its pharmaceuticals protect and repair tissue and organ damage caused by disease, trauma or othe...

$ 300.00

Read More

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummaryRegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. Its pharmaceuticals protect and repair tissue and organ damage caused by disease, trauma or othe...

$ 250.00

Read More

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummarySK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals) is a pharmaceutical company. It develops innovative drugs for the treatment of central nervous system (CNS) disorders such as epilepsy, anxiety, depression, schizophrenia, Parkinson's disease, irritable bowel syndrome; and metabolic diso...

$ 250.00

Read More

XTL Biopharmaceuticals Ltd. (084990) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical products in the areas of unmet clinical needs. The company has three product candidates such as ...

$ 250.00

Read More

Sino Biopharmaceutical Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 Mar 2015  |  Published by:  GlobalData
SummarySino Biopharmaceutical Limited (Sino) is a pharmaceutical company. The company operates through Chinese Medicines and Chemical Medicines segment, Investment Segment, and Other Segments. Its Chinese medicines and chemical medicines segment manufactures, sells and distributes modernized Chinese...

$ 250.00

Read More

NGM Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 Mar 2015  |  Published by:  GlobalData
SummaryNGM Biopharmaceuticals, Inc. (NGM) is a pharmaceutical company. It manufactures pharmaceutical ingredients and intermediate products that are used in animal and human health. The company's products include finished dosage forms, diminazene aceturate granules and homidium chloride tablets. NGM...

$ 250.00

Read More

Provenance Biopharmaceuticals Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 Mar 2015  |  Published by:  GlobalData
SummaryProvenance Biopharmaceuticals Corp. (Provenance) is a biopharmaceutical company. It develops immunotherapeutics to treat cancer and other serious life threatening diseases. The company develops antibody technologies. Provenance has a license agreement with Merck Serono for the development and...

$ 250.00

Read More

NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2015

26 Mar 2015  |  Published by:  Global Markets Direct
Summary‘NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the NGM Biopharmaceuticals, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of NGM Biopharmaceuticals,...

$ 1,500.00

Read More

Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2015

26 Mar 2015  |  Published by:  Global Markets Direct
Summary‘Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2015’, provides an overview of the Paras Biopharmaceuticals Finland Oy’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Paras Bio...

$ 1,500.00

Read More

Kythera Biopharmaceuticals, Inc. (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Mar 2015  |  Published by:  GlobalData
SummaryKythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline product include ATX-101. Kythera’s ATX-101 is an injectable drug, which is currently in late stag...

$ 250.00

Read More

Gallus BioPharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Mar 2015  |  Published by:  GlobalData
SummaryGallus BioPharmaceuticals, LLC (Gallus) is a biopharmaceutical company. The company provides contract manufacturing services for the pharmaceutical and biotechnology industry. Its services include protein expertise, process development, analytical method development, process validation, regul...

$ 250.00

Read More
Total 94 records.